c-Jun Proto-Oncoprotein Plays a Protective Role in Lung Epithelial Cells Exposed to Staphylococcal α-Toxin

Introduction

Staphylococcus aureus is a primary health concern worldwide, being the etiological agent of diverse infections that span from mild to life-threatening (Chambers and Deleo, 2009; DeLeo et al., 2010). To achieve invasion and colonization of the host, S. aureus is able to display an assortment of virulence factors among which the hla-encoded α-toxin (also referred to as α-hemolysin) outstands as a focus of intense research because of its key role in the establishment of severe infections such as sepsis or pneumonia (Bubeck Wardenburg et al., 2007; Berube and Bubeck Wardenburg, 2013).

Monomers of Hla assemble to form a homoheptameric ring which pokes into the plasma membrane to function as a pore-forming toxin (PFT) (Gouaux, 1998; Menestrina et al., 2001; Montoya and Gouaux, 2003), an intercommunicating 2 nm channel that leads to the loss of cellular potassium and calcium homeostasis (Below et al., 2009; Eichstaedt et al., 2009; Kloft et al., 2009; Eiffler et al., 2016). In this sense, it has been observed that staphylococcal α-toxin per se is able to trigger cellular defense responses such as production of IL-6 and IL-8, autophagy, and activation of p38 and ERK signaling pathways, among many others (Ratner et al., 2006; Gonzalez et al., 2008; Below et al., 2009; Kloft et al., 2009; Mestre et al., 2010). Importantly, immediate downstream activation targets of MAPKs are the members of the AP-1 transcription complex—early responsive genes which have a primary role in central cellular functions such as proliferation, apoptosis, tumorigenesis, differentiation, and survival upon stress (Hess et al., 2004; Vesely et al., 2009; Shaulian, 2010; Yogev et al., 2010; Papoudou-Bai et al., 2016). One of the main components of AP-1 is c-Jun, the expression of which can be stimulated by a wide array of extracellular stimuli (Hess et al., 2004; Anzi et al., 2008; Vesely et al., 2009; Shaulian, 2010; Yogev et al., 2010; Papoudou-Bai et al., 2016). Moreover, these same stimuli can turn c-Jun transcriptionally active by inducing phosphorylation of its residues Ser63 and Ser73 in its N-terminal domain. This activation is generally mediated by one or more MAPKs, notably by JNK, ERK, and p38 signaling pathways (Dérijard et al., 1994; Morton et al., 2003; Humar et al., 2007; Meng and Xia, 2011). Interestingly, the three MAPKs are known to become phosphorylated when cells are exposed to α-toxin or other bacterial PFTs (Ratner et al., 2006; Aguilar et al., 2009; Below et al., 2009; Kloft et al., 2009; Porta et al., 2010; Gonzalez et al., 2011; Kao et al., 2011; Räth et al., 2013). However, apart from a single recent study (Kao et al., 2011), c-Jun has never been implicated as being part of the cellular response to PFTs such as the staphylococcal α-toxin.

By using A549 cells, derived from lung epithelium which is a target tissue of severe staphylococcal infections such as necrotizing pneumonia, we show that α-toxin induced early activation of c-Jun whilst prompting its proteasomal degradation. Furthermore, we demonstrate that c-Jun contributed to withstand the damage induced by α-toxin, thereby promoting cell survival. Thus, we expand the repertory of manifold functions known for c-Jun by enlisting it as part of the early cellular response to staphylococcal infections.

Materials and Methods

Cell Culture and Treatment With Staphylococcal α-Toxin

Lung-derived epithelial A549 cells were routinely grown in Dulbecco's modified Eagle medium (DMEM; Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) (PAA Laboratories, Pasching, Austria) and antibiotics (100 U ml⁻¹ penicillin and 100 μg ml⁻¹ streptomycin; Gibco). Cells were then left overnight with serum-free medium and further treated or not with staphylococcal α-toxin (Sigma-Aldrich) 5 μg ml⁻¹ in fresh medium with 10% FBS for the corresponding time period.

All laboratory procedures were performed according to the Laboratory Safety Standards. Staphylococcal α-toxin was handled following the provider's recommendations.

siRNA-Mediated Knockdown

c-Jun and MAPKs were silenced in A549 cells using 100 nM of siRNA for c-Jun and JNK and, 25 nM for p38 and ERK (SignalSilence^®, Cell Signaling Technology) that were transfected with Lipofectamine™ RNAiMAX (Invitrogen) following the manufacturer's recommendations. Controls were carried out using SignalSilence^® Control siRNA (SCR). Subsequent to this, cells were exposed or not to the staphylococcal α-toxin followed by Western blot analyses.

Western Blotting

Western blots were carried out as described previously (Racca et al., 2011). Briefly, whole protein extracts of A549 cells were prepared in 5X Laemmli buffer containing 60 mM Tris-HCl pH 6.8, 10% glycerol, 2% sodium dodecyl sulfate (SDS), 1% 2-β-mercaptoethanol and 0.002% bromophenol blue. Total protein samples were separated on a 10% SDS-PAGE, and proteins were transferred to a nitrocellulose Hybond-ECL (Amersham Bioscience). The membranes were blocked in 5% non-fat milk in TBS (20 mM Tris-HCl, 150 mM NaCl pH 7.8), supplemented with 0.1% Tween-20 (TBS-T) 1 h at room temperature. Blots were incubated overnight with primary antibodies diluted in TBS-T at 4°C. The following antibodies were used: rabbit polyclonal anti-c-Jun (H-79; Santa Cruz Biotech.; 1:1000), rabbit monoclonal anti-phospho-c-Jun (Ser73) (#9164; Cell Signaling Technology; 1:1000), mouse monoclonal anti-β-actin (Sigma–Aldrich; 1:3000). After washing, the blots were incubated with horseradish peroxidase-conjugated donkey anti-rabbit or sheep anti-mouse IgG secondary antibodies (Amersham Bioscience; 1:5000) in TBS-T, at room temperature for 1 h. Protein-antibody complexes were visualized using an enhanced chemiluminescence detection system (SuperSignalWest Pico; Pierce) and exposed to Amersham Hyperfilm ECL. Ponceau staining (0.2% Ponceau, 3% tricloroactic acid, 3% sulfosalicilic acid) was used to verify protein transference from gel to nitrocellulose membrane. Band intensities were determined using Gel-Pro Analyzer software.

Quantitative Real Time PCR

Total RNA was extracted from cultured cells at the indicated times using GeneJET RNA Purification Kit (Thermo Fisher Scientific). One microgram of total RNA was reverse-transcribed in a total volume of 20 μl using random primers (Invitrogen) and 50 U M-MLV reverse transcriptase (Promega Corp.). c-Jun specific primers RT-cJun-For (5′-GACGATGCCCTCAACGCC-3′) and RT-cJun-Rev (5′-AGGATCTTGGGGTTACTGTAGCC-3′) were manually designed with the assistance of the Netprimer software (PREMIER Biosoft International, Palo Alto, CA). Primer sequences were compared against the human genomic and transcript data base with the BLAST program (Altschul et al., 1997) at the NCBI Web site. Specific transcripts were quantified by real time qRT-PCR (ABI 7500 Sequence Detection System, Applied Biosystems) using the Sequence Detection Software v1.4. Experiments were performed using 1x SYBR Green PCR Master Mix (Applied Biosystems). The cycling conditions included a hot start at 95°C for 10 min, followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. Specificity was verified by melting curve analysis and agarose gel electrophoresis. Fold change in gene expression was calculated according to the 2–ΔΔCt method (Livak and Schmittgen, 2001). Each sample was analyzed in triplicate. No amplification was observed in PCR reactions containing water or RNA samples incubated without reverse transcriptase during cDNA synthesis as template.

Determination of c-Jun Protein Degradation

A549 cells were treated with the proteasome pharmacological inhibitor MG132 (40 μM) (Sigma–Aldrich) for 30 min prior to treatment with α-toxin. Additionally, In order to clean off the effect of newly synthesized c-Jun, cells were also treated with cycloheximide (CHX) 1 μg/ml, which inhibits protein synthesis by blocking translational elongation. The vehicle DMSO was used as control.

Determination of Dehydrogenase Activity

Cell viability was evaluated by measuring dehydrogenase activity with the CellTiter 96^® A_queous Non-Radioactive Cell Proliferation Assay kit (Promega, Madison WI, USA) following the manufacturer's instructions. Briefly, A549 cells were plated in triplicate wells of a 96-well plate at a density of 3 × 10³ cells/well. The cells were incubated for 24 h at 37°C. Cell viability was measured after incubation for 2 h with a combined MTS/PMS solution by reading the plates at 490 nm with a microplate reader (Bio-Rad, Hercules, CA, USA). Viability was calculated from the absorbance ratio between values obtained at the end point with respect to those measured in cells before treatment. All assays were repeated 4 times.

Assessment of Cell Death by Annexin V/Propidium Iodide Double Staining Assay

A549 cell were cultured in complete growth medium, silenced for c-Jun using siRNA and exposed to α-toxin. After different time points post incubation, cells were harvested, washed and suspended in cold PBS. The proportion of cells undergoing cell death was examined by double staining using FITC labeled Annexin V and propidium iodide, as instructed by the manufacturer's protocol. At least 10,000 cells were analyzed and quadrant analysis was performed using FlowJo software version 7.6.2 (Tree Star, Inc., Ashland, OR). Viable cells are refractory to both staining agents. Cells in early stages of apoptosis stained as Annexin V⁺/Propidium iodide⁻, whereas cells in late apoptosis stained as Annexin V⁺/Propidium iodide⁺. Cells Annexin stained V⁻/Propidium iodide⁺ are considered necrotic.

Statistical Analysis

Statistical analyses were performed using GraphPad Prism version 5.03 software (GraphPad Sofware, San Diego, California, USA). The data were analyzed by one-way or two-way ANOVA when appropriate followed by Dunnet's or Bonferroni's post hoc tests, respectively. Kruskal-Wallis statistics was used for nonparametric adjustments followed by Dunn's multiple comparison test. In all cases, p-values less than or equal to 0.05 were considered statistically significant.

Results

α-Toxin Induces c-Jun Activation

Members of the AP-1 transcription factors are naturally activated via phosphorylation by a wide array of cellular and extracellular stimuli (Hess et al., 2004; Anzi et al., 2008; Vesely et al., 2009; Shaulian, 2010; Yogev et al., 2010; Papoudou-Bai et al., 2016). We wondered whether c-Jun, an early responsive transcription factor—could be activated after exposure of lung-derived cells to staphylococcal α-toxin.

For this purpose, we exposed A549 cells to α-toxin for different periods of time and followed the activation dynamics of c-Jun by examining its phosphorylation at its Ser73 residue, which mediates c-Jun activation. Thus, we analyzed cell extracts by Western blot using specific antibodies against this phosphorylated form of c-Jun.

As shown in Figure 1 and Figure S1, staphylococcal α-toxin significantly induced c-Jun phosphorylation after only 15 min of exposure. Interestingly, this activation response was accompanied with a concomitant decrease in the levels of total c-Jun, which is further described later in this study. These results indicate that α-toxin per se is sufficient to produce early activation of c-Jun, suggesting that this transcription factor could play a role in the cellular response against staphylococcal infections. Furthermore, staphylococcal α-toxin is able to decrease the protein levels of c-Jun which might carry subsequent implications in cellular fate.

FIGURE 1

Figure 1. Activation of c-Jun by staphylococcal α-toxin. Proteins were extracted from cultures of lung epithelial A549 cells which had been treated with α-toxin (5 μg ml-1) for 15–120 min or left untreated (NT). Western Blots were performed with specific antibodies against the phosphorylated and total fractions of c-Jun. Ponceau staining of total transferred proteins were used as loading controls. The panels illustrate typical blots obtained. Below the panels, relative protein levels are shown, with NT values normalized to 1.

The α-Toxin Induced Phosphorylation of c-Jun Occurs Through the JNK Pathway

Members of the AP-1 transcription factors are naturally activated via phosphorylation by MAPKs. Since it has already been observed that bacterial pore forming toxins induce the phosphorylation of MAPKs (Ratner et al., 2006; Aguilar et al., 2009; Below et al., 2009; Kloft et al., 2009; Porta et al., 2010; Gonzalez et al., 2011; Kao et al., 2011; Räth et al., 2013), we wondered whether these could, in turn, mediate c-Jun phosphorylation after exposure to staphylococcal α-toxin. Thus, we evaluated the role of JNK, p38, and ERK MAPKs in this response process, being JNK the main activator of c-Jun upon several different stimuli (Meng and Xia, 2011). In this sense, we observed the activation response of c-Jun in A549 cells which had been previously treated with specific pharmacological inhibitors of JNK, p38, or ERK (Figure 2A, Figure S2A. Alternatively, we also evaluated their contribution in this process by silencing the three MAPKs with the use of siRNA (Figure 2B, Figures S2B, S3).

FIGURE 2

Figure 2. Role of MAPKs in the α-toxin-induced activation of c-Jun. (A) Lung epithelial A549 cells were pretreated with the JNK inhibitor SP600125 (SP) 30 μM, the p38 inhibitor SB203580 (SB) 10 μM, or with the MEK1/2-ERK inhibitor U0126 (U0) 10 μM for 2 h, with the carrier DMSO being used to obtain uninhibited controls; (B) MAPKs were silenced using specific siRNAs for JNK (100 nM), p38 (25 nM), and ERK (25 nM). Controls were carried out using SignalSilence^® Control siRNA (SCR). Subsequent to inhibition/silencing, cells were exposed or not to the staphylococcal α-toxin (5 μg ml-1) for 30 and 120 min. Finally, the entire cell extracts were used for Western blotting by using specific antibodies against the phosphorylated and total fractions of c-Jun. Ponceau staining was carried out for loading controls. Pictures correspond to one representative assay of at least three independent experiments. NT, not treated. Below the panels, relative protein levels are shown, with NT values normalized to 1.

As shown in Figure 2 and Figure S2, pharmacological inhibition or knockdown of JNK by siRNA significantly reduced the phosphorylation of c-Jun in cells treated with α-toxin. On the contrary, basal and α-toxin-induced phosphorylation of c-Jun was increased in cells with knockdown or pharmacological inhibition of ERK. In fact, ERK inhibition/silencing also increased the levels of total c-Jun protein, counteracting the decrease observed at 120 min (Figure 2, Figure S2). A less clear effect was observed when the role of p38 was evaluated. While pharmacological inhibition of p38 produced a statistically non-significant increase in the activation as well as total protein levels of c-Jun, siRNA-derived knockdown of p38 produced no apparent modifications in the Ser73 phosphorylation. This could be probably attributed to off-target effects of the pharmacological p38 inhibitor. Alternatively, it is possible that even siRNA-mediated knock down levels of p38 that still conserve their intact catalytic capacities could be interfering in c-Jun phosphorylation.

Taken together, the results suggest that JNK is involved in the main signaling pathway that leads to α-toxin-induced activation of c-Jun. On the other hand, ERK seems to be carrying out a negative regulation on c-Jun in α-toxin-treated cells whereas the role of p38 is not clear.

Staphylococcal α-Toxin Induces the Degradation of c-Jun Protein

As shown in Figure 1 and Figure S1, the levels of total c-Jun decreases drastically after 30–60 min of treatment with α-toxin. There are two main possible pathways to achieve this outcome. The first is a decrease in the amount of transcripts of c-Jun followed by the concomitant lesser synthesis of the c-Jun protein. The second is an alteration in the stability and further degradation of the c-Jun protein provoked by those α-toxin-derived stimuli.

In order to test the first possibility, we performed real-time PCR to measure the amount of c-jun transcripts. We carried out these analyses by purifying RNA from A549 cells treated with α-toxin using the same time periods of exposure described above. Surprisingly, in clear opposition to the decrease observed in protein levels, the transcript levels of c-Jun increased steadily until 90 min of exposure to the toxin, followed by a slight decrease at 120 min (Figure 3A). This result cannot explain the observations on protein levels and puts forward the hypothesis of an increased protein instability and degradation.

FIGURE 3

Figure 3. Effect of α-toxin on the expression and stability of c-Jun. (A) Total mRNA was extracted from A549 cells which had been treated with α-toxin (5 μg ml-1) for 15 to 120 min or left untreated (NT). Subsequently, the amounts of c-Jun transcripts were determined by Quantitative real time PCR. Measurements were carried out in triplicate for three independent experiments, and the results are expressed as means with their SEM. Statistically significant differences at P < 0.05 are identified by * (Kruskal-Wallis followed by Dunn's multiple comparison test). (B) A549 cells were treated with the translational inhibitor cycloheximide (CHX, 1 μg ml-1), the proteasome pharmacological inhibitor MG132 (40 μM) or, the combination of both for 30 min, with the carrier DMSO being used for control experiments. Subsequently, cells were exposed to α-toxin (5 μg ml-1) for 15 to 120 min or left untreated (NT). Western Blots were performed with specific antibodies against c-Jun. Ponceau staining of total transferred proteins were used as loading controls. The panels illustrate typical blots obtained from 4 independent experiments.

To test the second alternative, we analyzed if α-toxin was able to induce degradation of c-Jun, thereby contributing to the reduction in the amount of protein observed. It has been established that elimination of c-Jun naturally occurs via polyubiquitination and subsequent degradation by the proteasome (Treier et al., 1994; Salvat et al., 1998). In this sense, we analyzed the effect of α-toxin on A549 cells which have been previously treated with cycloheximide (CHX) for protein synthesis inhibition, or CHX combined with MG132, a selective proteasome inhibitor. As shown in Figure 3B, the use of MG132 in addition to CHX rescued the levels of c-Jun in cells treated with α-toxin. Treatment of cells with MG132 alone rendered even more accumulation of c-Jun protein due to both, the contribution of de novo c-Jun biosynthesis and impaired degradation upon proteasome inhibition.

The decrease of c-Jun observed at longer exposures times (90–120 min) in CHX+MG132 treated cells could be due to partial inhibition of the proteasomal pathway by MG132 or, alternatively, due to other mechanisms of protein degradation.

These results suggest that a strong induction of protein degradation but not a reduced expression at mRNA level is the primary cause of the α-toxin-induced decrease observed in the protein levels of c-Jun.

C-Jun Plays a Protective Role Upon α-Toxin-Mediated Intoxication

In an initial attempt to investigate the biological contribution of c-Jun in the context of α-toxin exposure, we silenced c-Jun expression in A549 cells and we quantified dehydrogenase activity as a mitochondrial indicator of cell viability (Figure 4A). We compared the effect of α-toxin on cells with basal or knocked-down levels of c-Jun (Figure 4C). As shown in Figure 4A, cell viability upon treatment with α-toxin was significantly higher in those cells with normal levels of c-Jun compared to those in which c-Jun was silenced.

FIGURE 4

Figure 4. Role of c-Jun in the viability of cells treated with α-toxin. (A) Dehydrogenase activity assays: A549 cells with normal (SCR) or knockdown (sic-Jun) levels of c-Jun were exposed to α-toxin (5 μg ml-1) for 4 h or left untreated. Cell viability was measured after incubation for 2 h with a combined MTS/PMS solution by reading absorbance at 490 nm with a microplate reader (Bio-Rad, Hercules, CA, USA). Viability was calculated from the absorbance ratio between values obtained at the end point with respect to those measured in SCR untreated cells. Measurements were carried out in triplicate for 4 independent experiments, and the results are expressed as means with their SEM. Statistically significant differences at P < 0.001, P < 0.01, and P < 0.05 are identified by ***, **, and *, respectively (one-way ANOVA followed by Dunnet's post hoc test). (B) Flow-cytometry analyses: A549 cells with normal (SCR) or knockdown (sic-Jun) levels of c-Jun were exposed to α-toxin (5 μg ml-1) for 4 h or left untreated. Subsequently, cells were double stained with propidium iodide and the fluorescence-labeled annexin V followed by flow cytometric analyses to quantify cell death. One representative experiment of two is shown. (C) Knockdown of c-Jun was carried out using 25 nM of siRNA for c-Jun, using SignalSilence^® Control siRNA (SCR) for controls. A representative Western Blot performed with specific antibodies against c-Jun is shown. Ponceau staining of total transferred proteins were used as loading controls.

In order to reinforce this observation, we also quantified the induction apoptosis and necrosis by Annexin V/Propidium iodide double staining assay. In line with the results of dehydrogenase activity, when comparing cells with normal or silenced levels of c-Jun exposed to α-toxin we observed that knockdown of c-Jun increased the proportion of late apoptosis/necrosis (Figure 4B).

Taken together, the results from dehydrogenase activity and late apoptosis/necrosis quantification clearly indicate that c-Jun contributes to cope with the damage produced by the pore-forming α-toxin, thus promoting cell survival. Our results suggest that in the context of staphylococcal infections, c-Jun constitutes a part of the early-responsive repertory favoring cell survival.

Discussion

In the present study we evaluated the effect of α-toxin, a main S. aureus virulence factor on c-Jun, a central early responsive cell cycle modulator that belongs to the AP-1 family of transcriptional regulators. c-Jun participates in a wide range of cellular functions such as proliferation, apoptosis, tumorigenesis and differentiation (Wisdom et al., 1999; Hess et al., 2004; Papoudou-Bai et al., 2016). In this work we expand this range by providing insights in a poorly explored field of c-Jun, which is its role in the context of bacterial infections. Our results indicate that the staphylococcal α-toxin per se is sufficient to produce early phosphorylation of c-Jun at its Ser73 residue, which has been profusely documented as a post-translational modification leading to an enhanced transcriptional activity of c-Jun. Noteworthy, this increased phosphorylation level is accompanied by a decrease in the amount of total c-Jun because of proteasomal degradation.

A549 cells derive from human lung adenocarcinoma, and as such they might show intrinsically unbalanced responses to different stimuli such as toxins. Interestingly, this c-Jun response seems not to be confined to a response of A549 cells to staphylococcal α-toxin, since own preliminary results showed that MEF cells underwent an equivalent c-Jun activation process along with a decrease in total protein levels of c-Jun after being exposed to Vibrio cholera cytolysin (VCC) (Figure S4), another PFT able to trigger severe pathogenic processes on eukaryotic cells (McCardell et al., 1985; Gutierrez et al., 2007; Saka et al., 2007, 2008; Khilwani and Chattopadhyay, 2015). Thus, this early phosphorylation-mediated activation of c-Jun could play an important role in the cell defense response upon intoxication with bacterial PFTs. In this sense, the results from dehydrogenase activity and Annexin V/Propidium iodide double staining clearly indicate that c-Jun contributes to cope with the damage produced by the pore-forming α-toxin favoring cell survival. In line with previous reported information, we observed that α-toxin mediated death, in cells with or knock-down levels of c-Jun involved mainly necrosis and late apoptosis/necrosis whereas apoptosis was almost undetected (Essmann et al., 2003). Coincidently, a previous study described a similar protective role for c-Jun when cells are exposed to two other bacterial pore forming toxins, namely CryB5 from Bacillus thuringiensis and streptolysin O from Streptococcus pyogenes (Kao et al., 2011). In addition, these authors also showed that both PFTs are able to increase the transcripts of c-Jun as we did observe here for α-toxin. Nevertheless, here we showed that the increase in transcripts induced by α-toxin was clearly opposite to the response at protein levels. It has been demonstrated that the c-Jun promoter and gene expression can be activated by its own c-Jun/AP1 protein product through an autocrine amplification loop mechanism (Angel et al., 1988b; Meng and Xia, 2011). In this sense, the α-toxin-induced activation of c-Jun protein could help to explain the increase of c-Jun mRNA levels. Concomitantly, c-Jun degradation could be part of a cell safeguard mechanism to avoid deleterious effects of prolonged c-Jun activation on cell physiology. Another exciting possibility is that the increased expression of c-Jun mRNA is the consequence of an early cell response aimed to cope with the damage triggered by α-toxin, which involves degradation of c-Jun protein as part of the pathogenic process.

Activation of c-Jun can be mediated by different MAPKs, depending on the stimulus (Dérijard et al., 1994; Morton et al., 2003; Humar et al., 2007; Meng and Xia, 2011). We observed that α-toxin-dependent activation of c-Jun occurs mainly via JNK. Accordingly, VCC-induced activation of c-Jun in MEF cells was also abrogated upon pharmacological inhibition of JNK (Figure S4). In agreement with the decrease in c-Jun observed after inhibition/silencing of JNK (Figure 2), it has been reported that phosphorylation of c-Jun on its Ser73 by JNK protects c-Jun from ubiquitination, thereby prolonging its half-life (Fuchs et al., 1996). Interestingly, JNK but not p38 was found to be a key regulator of the transcriptional and functional response to PFTs in a C. elegans model (Kao et al., 2011). On the other hand, ERK exerts a negative regulation on c-Jun. In relation to this, we have recently observed that silencing of ERK exacerbates the activation of JNK as part of a crosstalk phenomenon that occurs when cells are intoxicated with α-toxin (unpublished observation). This could help to explain the increase in the toxin-induced activation of c-Jun in ERK-depleted cells. However, another possibility is that ERK could be helping in the instability of c-Jun caused by α-toxin. In this sense, it has been observed in vitro that ERK is able to phosphorylate c-Jun at its Ser243 residue (Morton et al., 2003), which was in turn established to be required for GSK3-dependent phosphorylation of Thr239 and further polyubiquitination and degradation (Wei et al., 2005). Thus, it is tempting to speculate that the early activation followed by proteasomal degradation of c-Jun could serve to trigger the cell nuclear response while avoiding the positive effects of c-Jun on cell proliferation (Eferl and Wagner, 2003).

It has been reported that staphylococcal α-toxin is also able to modify the expression of c-Fos (Below et al., 2009; Kao et al., 2011), the main partner of c-Jun to compose the AP-1 transcription factor complex (Angel et al., 1988a; Harshman et al., 1988; Rauscher et al., 1988a,b). However, in opposition to the degradation of c-Jun that we observed here, α-toxin induces an increase in the protein levels of c-Fos (Below et al., 2009), with this induced expression being positively regulated by the MEK1/2-ERK pathway.

This study sheds light on a previously underexplored role of c-Jun as an early regulator of cellular response to bacterial PFTs. Undoubtedly, future transcriptome/proteome-based studies as well as deeper analyses of its post-translational modifications will be required to fully comprehend the role of c-Jun in the context of microbial infections.

Author Contributions

AM, AR, GS, VA, and HS performed experiments. AM, HS, AS, CS, and JB analyzed data. AM, HS, and JB designed the study. AM and JB wrote the paper.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This work was supported by the Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT—PICT 2015-0543 to JB); PAE-GSK 0005 MINCyT-GlaxoSimthKline; Subsidio Instituto Nacional del Cancer to JB; and Secretaría de Ciencia y Tecnología–Universidad Nacional de Córdoba (SECyT-UNC 2015–2016).

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2018.00170/full#supplementary-material

References

Aguilar, J. L., Kulkarni, R., Randis, T. M., Soman, S., Kikuchi, A., Yin, Y., et al. (2009). Phosphatase-dependent regulation of epithelial mitogen-activated protein kinase responses to toxin-induced membrane pores. PLoS ONE 4:e8076. doi: 10.1371/journal.pone.0008076

PubMed Abstract | CrossRef Full Text | Google Scholar

Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., et al. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389–3402. doi: 10.1093/nar/25.17.3389

PubMed Abstract | CrossRef Full Text | Google Scholar

Angel, P., Allegretto, E. A., Okino, S. T., Hattori, K., Boyle, W. J., Hunter, T., et al. (1988a). Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 332, 166–171. doi: 10.1038/332166a0

PubMed Abstract | CrossRef Full Text | Google Scholar

Angel, P., Hattori, K., Smeal, T., and Karin, M. (1988b). The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55, 875–885. doi: 10.1016/0092-8674(88)90143-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Anzi, S., Finkin, S., and Shaulian, E. (2008). Transcriptional repression of c-Jun's E3 ubiquitin ligases contributes to c-Jun induction by UV. Cell. Signal. 20, 862–871. doi: 10.1016/j.cellsig.2007.12.020

PubMed Abstract | CrossRef Full Text | Google Scholar

Below, S., Konkel, A., Zeeck, C., Müller, C., Kohler, C., Engelmann, S., et al. (2009). Virulence factors of Staphylococcus aureus induce Erk-MAP kinase activation and c-Fos expression in S9 and 16HBE14o- human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L470–L479. doi: 10.1152/ajplung.90498.2008

PubMed Abstract | CrossRef Full Text | Google Scholar

Berube, B. J., and Bubeck Wardenburg, J. (2013). Staphylococcus aureus alpha-toxin: nearly a century of intrigue. Toxins 5, 1140–1166. doi: 10.3390/toxins5061140

PubMed Abstract | CrossRef Full Text | Google Scholar

Bubeck Wardenburg, J., Bae, T., Otto, M., Deleo, F. R., and Schneewind, O. (2007). Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13, 1405–1406. doi: 10.1038/nm1207-1405

PubMed Abstract | CrossRef Full Text | Google Scholar

Chambers, H. F., and Deleo, F. R. (2009). Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629–641. doi: 10.1038/nrmicro2200

PubMed Abstract | CrossRef Full Text | Google Scholar

DeLeo, F. R., Otto, M., Kreiswirth, B. N., and Chambers, H. F. (2010). Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375, 1557–1568. doi: 10.1016/S0140-6736(09)61999-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Dérijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., et al. (1994). JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025–1037. doi: 10.1016/0092-8674(94)90380-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Eferl, R., and Wagner, E. F. (2003). AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859–868. doi: 10.1038/nrc1209

PubMed Abstract | CrossRef Full Text | Google Scholar

Eichstaedt, S., Gäbler, K., Below, S., Müller, C., Kohler, C., Engelmann, S., et al. (2009). Effects of Staphylococcus aureus-hemolysin A on calcium signalling in immortalized human airway epithelial cells. Cell Calcium 45, 165–176. doi: 10.1016/j.ceca.2008.09.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Eiffler, I., Behnke, J., Ziesemer, S., Müller, C., and Hildebrandt, J. P. (2016). Staphylococcus aureus α-toxin-mediated cation entry depolarizes membrane potential and activates p38 MAP kinase in airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 311, L676–L685. doi: 10.1152/ajplung.00090.2016

PubMed Abstract | CrossRef Full Text | Google Scholar

Essmann, F., Bantel, H., Totzke, G., Engels, I. H., Sinha, B., Schulze-Osthoff, K., et al. (2003). Staphylococcus aureus α-toxin-induced cell death: predominant necrosis despite apoptotic caspase activation. Cell Death Differ. 10, 1260–1272. doi: 10.1038/sj.cdd.4401301

PubMed Abstract | CrossRef Full Text | Google Scholar

Fuchs, S. Y., Dolan, L., Davis, R. J., and Ronai, Z. (1996). Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 13, 1531–1535.

PubMed Abstract | Google Scholar

Gonzalez, M. R., Bischofberger, M., Frêche, B., Ho, S., Parton, R. G., and van der Goot, F. G. (2011). Pore-forming toxins induce multiple cellular responses promoting survival. Cell. Microbiol. 13, 1026–1043. doi: 10.1111/j.1462-5822.2011.01600.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Gonzalez, M. R., Bischofberger, M., Pernot, L., van der Goot, F. G., and Frêche, B. (2008). Bacterial pore-forming toxins: the (w)hole story? Cell. Mol. Life Sci. 65, 493–507. doi: 10.1007/s00018-007-7434-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Gouaux, E. (1998). α-Hemolysin from Staphylococcus aureus: an archetype of beta-barrel, channel-forming toxins. J. Struct. Biol. 121, 110–122. doi: 10.1006/jsbi.1998.3959

PubMed Abstract | CrossRef Full Text | Google Scholar

Gutierrez, M. G., Saka, H. A., Chinen, I., Zoppino, F. C., Yoshimori, T., Bocco, J. L., et al. (2007). Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V. cholerae. Proc. Natl. Acad. Sci. U.S.A. 104, 1829–1834. doi: 10.1073/pnas.0601437104

CrossRef Full Text

Harshman, K. D., Moye-Rowley, W. S., and Parker, C. S. (1988). Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4. Cell 53, 321–330. doi: 10.1016/0092-8674(88)90393-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Hess, J., Angel, P., and Schorpp-Kistner, M. (2004). AP-1 subunits: quarrel and harmony among siblings. J. Cell. Sci. 117(Pt 25), 5965–5973. doi: 10.1242/jcs.01589

PubMed Abstract | CrossRef Full Text | Google Scholar

Humar, M., Loop, T., Schmidt, R., Hoetzel, A., Roesslein, M., Andriopoulos, N., et al. (2007). The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun. Int. J. Biochem. Cell Biol. 39, 2278–2288. doi: 10.1016/j.biocel.2007.06.013

PubMed Abstract | CrossRef Full Text | Google Scholar

Kao, C. Y., Los, F. C., Huffman, D. L., Wachi, S., Kloft, N., Husmann, M., et al. (2011). Global functional analyses of cellular responses to pore-forming toxins. PLoS Pathog. 7:e1001314. doi: 10.1371/journal.ppat.1001314

PubMed Abstract | CrossRef Full Text | Google Scholar

Khilwani, B., and Chattopadhyay, K. (2015). Signaling beyond punching holes: modulation of cellular responses by Vibrio cholerae cytolysin. Toxins 7, 3344–3358. doi: 10.3390/toxins7083344

PubMed Abstract | CrossRef Full Text | Google Scholar

Kloft, N., Busch, T., Neukirch, C., Weis, S., Boukhallouk, F., Bobkiewicz, W., et al. (2009). Pore-forming toxins activate MAPK p38 by causing loss of cellular potassium. Biochem. Biophys. Res. Commun. 385, 503–506. doi: 10.1016/j.bbrc.2009.05.121

PubMed Abstract | CrossRef Full Text | Google Scholar

Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-^ΔΔC(T)) method. Methods 25, 402–408. doi: 10.1006/meth.2001.1262

CrossRef Full Text | Google Scholar

McCardell, B. A., Madden, J. M., and Shah, D. B. (1985). Isolation and characterization of a cytolysin produced by Vibrio cholerae serogroup non-O1. Can. J. Microbiol. 31, 711–720. doi: 10.1139/m85-135

PubMed Abstract | CrossRef Full Text | Google Scholar

Menestrina, G., Serra, M. D., and Prevost, G. (2001). Mode of action of beta-barrel pore-forming toxins of the staphylococcal α-hemolysin family. Toxicon 39, 1661–1672. doi: 10.1016/S0041-0101(01)00153-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Meng, Q., and Xia, Y. (2011). c-Jun, at the crossroad of the signaling network. Protein Cell 2, 889–898. doi: 10.1007/s13238-011-1113-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Mestre, M. B., Fader, C. M., Sola, C., and Colombo, M. I. (2010). α-hemolysin is required for the activation of the autophagic pathway in Staphylococcus aureus-infected cells. Autophagy 6, 110–125. doi: 10.4161/auto.6.1.10698

PubMed Abstract | CrossRef Full Text | Google Scholar

Montoya, M., and Gouaux, E. (2003). β-barrel membrane protein folding and structure viewed through the lens of α-hemolysin. Biochim. Biophys. Acta 1609, 19–27. doi: 10.1016/S0005-2736(02)00663-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Morton, S., Davis, R. J., McLaren, A., and Cohen, P. (2003). A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 22, 3876–3886. doi: 10.1093/emboj/cdg388

PubMed Abstract | CrossRef Full Text | Google Scholar

Papoudou-Bai, A., Hatzimichael, E., Barbouti, A., and Kanavaros, P. (2016). Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms. Clin. Exp. Med. 17, 291–304. doi: 10.1007/s10238-016-0436-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Porta, H., Cancino-Rodezno, A., Soberón, M., and Bravo, A. (2010). Role of MAPK p38 in the cellular responses to pore-forming toxins. Peptides 32, 601–606. doi: 10.1016/j.peptides.2010.06.012

PubMed Abstract | CrossRef Full Text | Google Scholar

Racca, A. C., Camolotto, S. A., Ridano, M. E., Bocco, J. L., Genti-Raimondi, S., and Panzetta-Dutari, G. M. (2011). Kruppel-like factor 6 expression changes during trophoblast syncytialization and transactivates sshCG and PSG placental genes. PLoS ONE 6:e22438. doi: 10.1371/journal.pone.0022438

PubMed Abstract | CrossRef Full Text | Google Scholar

Räth, S., Ziesemer, S., Witte, A., Konkel, A., Müller, C., Hildebrandt, P., et al. (2013). S. aureus haemolysin A-induced IL-8 and IL-6 release from human airway epithelial cells is mediated by activation of p38- and Erk-MAP kinases and additional, cell type-specific signalling mechanisms. Cell Microbiol. 15, 1253–1265. doi: 10.1111/cmi.12113

PubMed Abstract | CrossRef Full Text | Google Scholar

Ratner, A. J., Hippe, K. R., Aguilar, J. L., Bender, M. H., Nelson, A. L., and Weiser, J. N. (2006). Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J. Biol. Chem. 281, 12994–12998. doi: 10.1074/jbc.M511431200

PubMed Abstract | CrossRef Full Text | Google Scholar

Rauscher, F. J. III., Cohen, D. R., Curran, T., Bos, T. J., Vogt, P. K., Bohmann, D., et al. (1988a). Fos-associated protein p39 is the product of the jun proto-oncogene. Science 240, 1010–1016. doi: 10.1126/science.3130660

PubMed Abstract | CrossRef Full Text | Google Scholar

Rauscher, F. J. III., Voulalas, P. J., Franza, B. R. Jr., and Curran, T. (1988b). Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev. 2, 1687–1699. doi: 10.1101/gad.2.12b.1687

PubMed Abstract | CrossRef Full Text | Google Scholar

Saka, H. A., Bidinost, C., Sola, C., Carranza, P., Collino, C., Ortiz, S., et al. (2008). Vibrio cholerae cytolysin is essential for high enterotoxicity and apoptosis induction produced by a cholera toxin gene-negative V. cholerae non-O1, non-O139 strain. Microb. Pathog. 44, 118–128. doi: 10.1016/j.micpath.2007.08.013

PubMed Abstract | CrossRef Full Text | Google Scholar

Saka, H. A., Gutiérrez, M. G., Bocco, J. L., and Colombo, M. I. (2007). The autophagic pathway: a cell survival strategy against the bacterial pore-forming toxin Vibrio cholerae cytolysin. Autophagy 3, 363–365. doi: 10.4161/auto.4159

PubMed Abstract | CrossRef Full Text | Google Scholar

Salvat, C., Jariel-Encontre, I., Acquaviva, C., Omura, S., and Piechaczyk, M. (1998). Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts. Oncogene 17, 327–337. doi: 10.1038/sj.onc.1201922

PubMed Abstract | CrossRef Full Text | Google Scholar

Shaulian, E. (2010). AP-1–The Jun proteins: oncogenes or tumor suppressors in disguise? Cell. Signal. 22, 894–899. doi: 10.1016/j.cellsig.2009.12.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Treier, M., Staszewski, L. M., and Bohmann, D. (1994). Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787–798. doi: 10.1016/S0092-8674(94)90502-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Vesely, P. W., Staber, P. B., Hoefler, G., and Kenner, L. (2009). Translational regulation mechanisms of AP-1 proteins. Mutat. Res. 682, 7–12. doi: 10.1016/j.mrrev.2009.01.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Wei, W., Jin, J., Schlisio, S., Harper, J. W., and Kaelin, W. G. Jr. (2005). The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8, 25–33. doi: 10.1016/j.ccr.2005.06.005

PubMed Abstract | CrossRef Full Text | Google Scholar

Wisdom, R., Johnson, R. S., and Moore, C. (1999). c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18, 188–197. doi: 10.1093/emboj/18.1.188

PubMed Abstract | CrossRef Full Text | Google Scholar

Yogev, O., Goldberg, R., Anzi, S., and Shaulian, E. (2010). Jun proteins are starvation-regulated inhibitors of autophagy. Cancer Res. 70, 2318–2327. doi: 10.1158/0008-5472.CAN-09-3408

PubMed Abstract | CrossRef Full Text | Google Scholar